These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 25172933)
41. Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway. Feng J; Yan PF; Zhao HY; Zhang FC; Zhao WH; Feng M Biomed Res Int; 2016; 2016():1450843. PubMed ID: 28097126 [TBL] [Abstract][Full Text] [Related]
42. Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo. Formentini L; Moroni F; Chiarugi A Biochem Pharmacol; 2009 May; 77(10):1612-20. PubMed ID: 19426698 [TBL] [Abstract][Full Text] [Related]
43. Endogenous NAMPT dampens chemokine expression and apoptotic responses in stressed tubular cells. Benito-Martin A; Ucero AC; Izquierdo MC; Santamaria B; Picatoste B; Carrasco S; Lorenzo O; Ruiz-Ortega M; Egido J; Ortiz A Biochim Biophys Acta; 2014 Feb; 1842(2):293-303. PubMed ID: 24287278 [TBL] [Abstract][Full Text] [Related]
44. New Analogues of the Nicotinamide Phosphoribosyltransferase Inhibitor FK866 as Potential Anti-Pancreatic Cancer Agents. Conforti I; Benzi A; Caffa I; Bruzzone S; Nencioni A; Marra A Med Chem; 2024; 20(7):694-708. PubMed ID: 38333979 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced inflammatory responses of human monocytes. Schilling E; Wehrhahn J; Klein C; Raulien N; Ceglarek U; Hauschildt S Innate Immun; 2012 Jun; 18(3):518-30. PubMed ID: 21975728 [TBL] [Abstract][Full Text] [Related]
46. The NAMPT inhibitor FK866 reverts the damage in spinal cord injury. Esposito E; Impellizzeri D; Mazzon E; Fakhfouri G; Rahimian R; Travelli C; Tron GC; Genazzani AA; Cuzzocrea S J Neuroinflammation; 2012 Apr; 9():66. PubMed ID: 22490786 [TBL] [Abstract][Full Text] [Related]
47. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia. McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055 [TBL] [Abstract][Full Text] [Related]
48. Targeting of nicotinamide phosphoribosyltransferase enzymatic activity ameliorates lung damage induced by ischemia/reperfusion in rats. Wu GC; Liao WI; Wu SY; Pao HP; Tang SE; Li MH; Huang KL; Chu SJ Respir Res; 2017 Apr; 18(1):71. PubMed ID: 28438162 [TBL] [Abstract][Full Text] [Related]
49. Anti-proliferation effect of APO866 on C6 glioblastoma cells by inhibiting nicotinamide phosphoribosyltransferase. Zhang LY; Liu LY; Qie LL; Ling KN; Xu LH; Wang F; Fang SH; Lu YB; Hu H; Wei EQ; Zhang WP Eur J Pharmacol; 2012 Jan; 674(2-3):163-70. PubMed ID: 22119381 [TBL] [Abstract][Full Text] [Related]
50. The nicotinamide phosphoribosyltransferase antagonist FK866 inhibits growth of prostate tumour spheroids and increases doxorubicin retention without changes in drug transporter and cancer stem cell protein expression. Sauer H; Kampmann H; Khosravi F; Sharifpanah F; Wartenberg M Clin Exp Pharmacol Physiol; 2021 Mar; 48(3):422-434. PubMed ID: 33349973 [TBL] [Abstract][Full Text] [Related]
51. The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies. Nahimana A; Attinger A; Aubry D; Greaney P; Ireson C; Thougaard AV; Tjørnelund J; Dawson KM; Dupuis M; Duchosal MA Blood; 2009 Apr; 113(14):3276-86. PubMed ID: 19196867 [TBL] [Abstract][Full Text] [Related]
52. Apoptosis induced by NAD depletion is inhibited by KN-93 in a CaMKII-independent manner. Takeuchi M; Yamamoto T Exp Cell Res; 2015 Jul; 335(1):62-7. PubMed ID: 26024774 [TBL] [Abstract][Full Text] [Related]
53. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia. Pahler JC; Ruiz S; Niemer I; Calvert LR; Andreeff M; Keating M; Faderl S; McConkey DJ Clin Cancer Res; 2003 Oct; 9(12):4570-7. PubMed ID: 14555532 [TBL] [Abstract][Full Text] [Related]
54. Distinct effects of Nampt inhibition on mild and severe models of lipopolysaccharide-induced myocardial impairment. Liu L; Wang P; Liang C; He D; Yu Y; Liu X Int Immunopharmacol; 2013 Oct; 17(2):342-9. PubMed ID: 23831038 [TBL] [Abstract][Full Text] [Related]
55. Nicotinamide phosphoribosyltransferase inhibitor APO866 induces C6 glioblastoma cell death via autophagy. Yang P; Zhang L; Shi QJ; Lu YB; Wu M; Wei EQ; Zhang WP Pharmazie; 2015 Oct; 70(10):650-5. PubMed ID: 26601421 [TBL] [Abstract][Full Text] [Related]
56. Apoptotic effect of fludarabine is independent of expression of IAPs in B-cell chronic lymphocytic leukemia. Silva KL; Vasconcellos DV; Castro ED; Coelho AM; Linden R; Maia RC Apoptosis; 2006 Feb; 11(2):277-85. PubMed ID: 16502265 [TBL] [Abstract][Full Text] [Related]
57. Up-regulation of nicotinamide phosphoribosyltransferase and increase of NAD+ levels by glucose restriction extend replicative lifespan of human fibroblast Hs68 cells. Yang NC; Song TY; Chang YZ; Chen MY; Hu ML Biogerontology; 2015 Feb; 16(1):31-42. PubMed ID: 25146190 [TBL] [Abstract][Full Text] [Related]
58. Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells. Yoon JY; Ishdorj G; Graham BA; Johnston JB; Gibson SB Apoptosis; 2014 Jan; 19(1):191-200. PubMed ID: 24057147 [TBL] [Abstract][Full Text] [Related]
59. Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma. Wang XY; Wang JZ; Gao L; Zhang FY; Wang Q; Liu KJ; Xiang B Toxicol Appl Pharmacol; 2017 Sep; 331():54-61. PubMed ID: 28501332 [TBL] [Abstract][Full Text] [Related]
60. Nicotinamide phosphoribosyltransferase production in human spermatozoa is influenced by maturation stage. Riammer S; Garten A; Schaab M; Grunewald S; Kiess W; Kratzsch J; Paasch U Andrology; 2016 Nov; 4(6):1045-1053. PubMed ID: 27566659 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]